Why metronidazole is active against both bacteria and parasites.
作者信息
Samuelson J
机构信息
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
出版信息
Antimicrob Agents Chemother. 1999 Jul;43(7):1533-41. doi: 10.1128/AAC.43.7.1533.
Abstract
摘要
相似文献
1
Why metronidazole is active against both bacteria and parasites.
Antimicrob Agents Chemother. 1999 Jul;43(7):1533-41. doi: 10.1128/AAC.43.7.1533.
2
Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.
J Antimicrob Chemother. 1991 Jul;28(1):47-53. doi: 10.1093/jac/28.1.47.
3
Distribution of metronidazole susceptibility factors in obligate anaerobes.
J Antimicrob Chemother. 1986 Nov;18(5):565-74. doi: 10.1093/jac/18.5.565.
4
Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica.
J Antimicrob Chemother. 1997 Dec;40(6):833-40. doi: 10.1093/jac/40.6.833.
5
Metabolic differences between metronidazole resistant and susceptible strains of Tritrichomonas foetus.
Mol Biochem Parasitol. 1984 Apr;11:105-18. doi: 10.1016/0166-6851(84)90058-6.
6
Ferredoxin involvement in metronidazole resistance of Giardia duodenalis.
Mol Biochem Parasitol. 2000 Apr 30;108(1):137-40. doi: 10.1016/s0166-6851(00)00194-8.
7
Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis.
Mol Biochem Parasitol. 1999 Jan 25;98(2):203-14. doi: 10.1016/s0166-6851(98)00169-8.
8
Metronidazole susceptibility factors in Actinobacillus actinomycetemcomitans.
J Antimicrob Chemother. 1995 Feb;35(2):263-9. doi: 10.1093/jac/35.2.263.
9
Possible roles for pyruvate:ferredoxin oxidoreductase and thiol-dependent peroxidase and reductase activities in resistance to nitroheterocyclic drugs in Giardia intestinalis.
Int J Parasitol. 1988 Nov;18(7):991-7. doi: 10.1016/0020-7519(88)90183-x.
10
Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.
Br J Vener Dis. 1980 Oct;56(5):285-90. doi: 10.1136/sti.56.5.285.
引用本文的文献
1
Genotype-Specific Small EVs Released by Giardia lamblia Act as Mediators of Phenotypic Adaptation Under Metronidazole-Induced Stress.
J Extracell Vesicles. 2025 Sep;14(9):e70139. doi: 10.1002/jev2.70139.
2
Clinical pharmacokinetics of metronidazole: a systematic review and meta-analysis.
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0190424. doi: 10.1128/aac.01904-24. Epub 2025 Jul 31.
3
Use, Risk and Revalorization of Veterinary Antibiotics: A Canadian Perspective.
Antibiotics (Basel). 2025 Jun 30;14(7):665. doi: 10.3390/antibiotics14070665.
4
Modern Technologies in Blepharitis Diagnosis and Therapy (Review).
Sovrem Tekhnologii Med. 2025;17(3):62-72. doi: 10.17691/stm2025.17.3.06. Epub 2025 Jun 30.
5
Gut Microbiota in a Viral Model of Multiple Sclerosis: Modulation and Pitfalls by Oral Antibiotic Treatment.
Cells. 2025 Jun 9;14(12):871. doi: 10.3390/cells14120871.
6
Disseminated and migratory sparganosis in the central nervous system: A case report and literature review of combined spinal and intracranial involvement.
Surg Neurol Int. 2025 May 16;16:189. doi: 10.25259/SNI_146_2025. eCollection 2025.
7
Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension.
Parasit Vectors. 2025 May 12;18(1):169. doi: 10.1186/s13071-025-06797-w.
8
Metronidazole Activation by a Deeply Entangled Dimeric Malic Enzyme in .
Pathogens. 2025 Mar 13;14(3):277. doi: 10.3390/pathogens14030277.
9
Current and Ongoing Developments in Targeting Infection and Recurrence.
Microorganisms. 2024 Jun 15;12(6):1206. doi: 10.3390/microorganisms12061206.
10
Comparison of in vitro Killing Effect of Thai Herbal Essential Oils, Tea Tree Oil, and Metronidazole 0.75% versus Ivermectin 1% on .
Clin Cosmet Investig Dermatol. 2023 May 18;16:1279-1286. doi: 10.2147/CCID.S414737. eCollection 2023.
本文引用的文献
1
Entamoeba histolytica as a model for the primitive eukaryotic cell.
Parasitol Today. 1993 Jan;9(1):27-31. doi: 10.1016/0169-4758(93)90161-8.
2
Crystalline alcohol dehydrogenases from the mesophilic bacterium Clostridium beijerinckii and the thermophilic bacterium Thermoanaerobium brockii: preparation, characterization and molecular symmetry.
Acta Crystallogr D Biol Crystallogr. 1996 Jul 1;52(Pt 4):882-6. doi: 10.1107/S0907444996001461.
3
Hsp60 is targeted to a cryptic mitochondrion-derived organelle ("crypton") in the microaerophilic protozoan parasite Entamoeba histolytica.
Mol Cell Biol. 1999 Mar;19(3):2198-205. doi: 10.1128/MCB.19.3.2198.
4
Sequence survey of the Giardia lamblia genome.
Mol Biochem Parasitol. 1998 Sep 15;95(2):267-80. doi: 10.1016/s0166-6851(98)00113-3.
5
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
Gut. 1998 Jul;43 Suppl 1(Suppl 1):S61-5. doi: 10.1136/gut.43.2008.s61.
6
Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials.
Br J Surg. 1998 Sep;85(9):1232-41. doi: 10.1046/j.1365-2168.1998.00883.x.
7
Aldehyde dehydrogenase (CoA-acetylating) and the mechanism of ethanol formation in the amitochondriate protist, Giardia lamblia.
Arch Biochem Biophys. 1998 Jun 1;354(1):57-64. doi: 10.1006/abbi.1998.0664.
8
Treatment of Clostridium difficile infection.
J Antimicrob Chemother. 1998 May;41 Suppl C:41-6. doi: 10.1093/jac/41.suppl_3.41.
9
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.
Mol Microbiol. 1998 Apr;28(2):383-93. doi: 10.1046/j.1365-2958.1998.00806.x.
10
Inhibition of recombinant human mitochondrial aldehyde dehydrogenase by two intermediate metabolites of disulfiram.
Biochem Pharmacol. 1998 Apr 1;55(7):1099-103. doi: 10.1016/s0006-2952(97)00686-2.
Zotero 插件